Ligand validation:4NXG

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 4NXG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NXG_FMN_B_601	72%	43%	0.109	0.932	1.06	1.19	2	7	0	0	100%	1
4NXG_FMN_A_601	69%	41%	0.117	0.932	1.08	1.28	2	8	0	0	100%	1
7ABY_FMN_A_500	95%	46%	0.068	0.974	0.96	1.15	2	7	1	0	100%	1
4NXF_FMN_B_1001	88%	44%	0.083	0.958	1.06	1.16	2	8	0	0	100%	1
4NXE_FMN_A_1001	84%	42%	0.098	0.961	1.07	1.23	2	9	0	0	100%	1
4NXB_FMN_B_1001	65%	38%	0.139	0.942	1.11	1.4	2	10	2	0	100%	1
4UTJ_FMN_A_1362	100%	21%	0.043	0.994	1.15	2.32	3	6	0	0	100%	1
6R2P_FMN_A_601	100%	28%	0.042	0.99	1.72	1.32	7	7	0	0	100%	1
7PGX_FMN_AAA_618	100%	62%	0.042	0.99	0.77	0.68	1	-	0	0	100%	1
4K8E_FMN_A_401	100%	46%	0.044	0.992	1.05	1.08	2	3	0	0	100%	1
4B5N_FMN_A_400	100%	53%	0.047	0.994	0.93	0.9	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.